• Explore /
  • Poster
  • / Interim analysis of STARTAR: A phase II salvage trial of androgen receptor (AR) inhibition with androgen deprivation therapy (ADT) and apalutamide with radiation therapy (RT) followed by docetaxel in men with PSA recurrent prostate cancer (PC) after radical prostatectomy (RP).

Interim analysis of STARTAR: A phase II salvage trial of androgen receptor (AR) inhibition with androgen deprivation therapy (ADT) and apalutamide with radiation therapy (RT) followed by docetaxel in men with PSA recurrent prostate cancer (PC) after radical prostatectomy (RP).

Abstract Video & Slides Poster

Authors

Tian Zhang

Tian Zhang

Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC

Tian Zhang , Bridget F. Koontz , Scott T. Tagawa , Himanshu Nagar , Rhonda L. Bitting , Bart Frizzell , Luke T. Nordquist , Julia Rasmussen , Rhonda Wilder , Monika Anand , Carolyn Winters , Colleen Riggan , Escarleth Fernandez , Patrick Healy , Taofik Oyekunle , Yuan Wu , Megan Ann McNamara , Michael Roger Harrison , Daniel J. George , Andrew J. Armstrong

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Prostate Cancer - Advanced Disease

Track

Prostate Cancer - Advanced

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03311555

Citation

J Clin Oncol 39, 2021 (suppl 6; abstr 90)

DOI

10.1200/JCO.2021.39.6_suppl.90

Abstract #

90

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Tian Zhang

First Author: Tian Zhang

First Author: Edwin Melencio Posadas

First Author: Andrew J. Armstrong